CFG
56
4
DG
36
-2
DVA
73
2
CTSH
49
-2
L
63
3
PLD
58
10
ILMN
23
-5
CAH
43
2
FOX
50
2
ABBV
64
4
SYF
83
2
SRE
61
14
AAL
50
2
EMC
85
38
BXP
52
-2
SNA
60
2
IP
62
-2
CI
49
3
APA
30
5
C
48
-2
CFG
56
4
DG
36
-2
DVA
73
2
CTSH
49
-2
L
63
3
PLD
58
10
ILMN
23
-5
CAH
43
2
FOX
50
2
ABBV
64
4
SYF
83
2
SRE
61
14
AAL
50
2
EMC
85
38
BXP
52
-2
SNA
60
2
IP
62
-2
CI
49
3
APA
30
5
C
48
-2
Financhill
Back

89bio Vs. Akero Therapeutics Industry Stock Comparison

Sell
48

ETNB
89bio

Last Price:
8.61
Seasonality Move:
15.69%
Sell
34

AKRO
Akero Therapeutics

Last Price:
19.94
Seasonality Move:
19.74%
Sell
48
89bio (ETNB) is a Sell

Is 89bio a Buy, Sell or Hold?

  • The current 89bio [ETNB] share price is $8.63. The Score for ETNB is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ETNB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $19.92. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ETNB Stock Price Chart

What is 89bio's stock price today?

  • The 89bio share price today is $8.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ETNB is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $19.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

ETNB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 40.33 Sell
Chaikin Money Flow: -669038 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.58 - 9.3) Sell
Bollinger Bands (100): (9.13 - 11.85) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.51 Sell
Relative Strength Index (14 RSI): 42.74 Sell
Chaikin Money Flow: -318844 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.75 - 21.41) Sell
Bollinger Bands (100): (20.09 - 25.99) Sell

ETNB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.93 Sell
20-day SMA: 8.88 Sell
50-day SMA: 10.24 Sell
200-day SMA: 11.29 Sell
8-day EMA: 8.93 Sell
20-day EMA: 9.1 Sell
50-day EMA: 9.72 Sell
200-day EMA: 11.09 Sell

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.51 Sell
20-day SMA: 20.4 Sell
50-day SMA: 22.86 Sell
200-day SMA: 27.08 Sell
8-day EMA: 20.5 Sell
20-day EMA: 20.8 Sell
50-day EMA: 21.92 Sell
200-day EMA: 26.48 Sell

89bio Earnings Growth & ETNB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.44 per share, and a decrease next year of $0.15 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.11 per share, a decrease this year of $1.06 per share, and a decrease next year of $0.47 per share.

89bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):